Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
4.430
-0.290 (-6.14%)
At close: Nov 20, 2024, 4:00 PM
4.300
-0.130 (-2.93%)
Pre-market: Nov 21, 2024, 7:00 AM EST
Acelyrin Market Cap
Acelyrin has a market cap or net worth of $444.44 million as of November 21, 2024. Its market cap has decreased by -51.22% in one year.
Market Cap
444.44M
Enterprise Value
-110.55M
1-Year Change
-51.22%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since the IPO on May 5, 2023, Acelyrin's market cap has decreased from $1.67B to $444.44M, a decrease of -73.36%. That is a compound annual growth rate of -57.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 473.54M | -34.79% |
| Dec 29, 2023 | 726.15M | -56.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Biosciences of California | 471.05M |
| Xeris Biopharma Holdings | 456.19M |
| MeiraGTx Holdings | 454.85M |
| Health Catalyst | 447.84M |
| SIGA Technologies | 446.28M |
| Korro Bio | 440.31M |
| National Research | 440.18M |
| Tango Therapeutics | 438.26M |